Wikipedia

Pleural cavity

(Redirected from Pleural diseases)

The pleural cavity, or pleural space (or sometimes intrapleural space), is the potential space between the pleurae of the pleural sac that surrounds each lung. A small amount of serous pleural fluid is maintained in the pleural cavity to enable lubrication between the membranes, and also to create a pressure gradient.[1]

Pleural cavity
The pleural cavity is the potential space between the pleurae of the pleural sac that surrounds each lung.
Details
PrecursorIntraembryonic coelom
Identifiers
Latincavum pleurae, cavum pleurale, cavitas pleuralis
MeSHD035422
TA98A07.1.01.001
TA23316
THH3.05.03.0.00013
FMA9740
Anatomical terminology

The serous membrane that covers the surface of the lung is the visceral pleura and is separated from the outer membrane, the parietal pleura, by just the film of pleural fluid in the pleural cavity. The visceral pleura follows the fissures of the lung and the root of the lung structures. The parietal pleura is attached to the mediastinum, the upper surface of the diaphragm, and to the inside of the ribcage.[1]

Structure

edit

In humans, the left and right lungs are completely separated by the mediastinum, and there is no communication between their pleural cavities. Therefore, in cases of a unilateral pneumothorax, the contralateral lung will remain functioning normally unless there is a tension pneumothorax, which may shift the mediastinum and the trachea, kink the great vessels and eventually collapse the contralateral cardiopulmonary circulation.

The visceral pleura receives its blood supply from the parenchymal capillaries of the underlying lung, which have input from both the pulmonary and the bronchial circulation. The parietal pleura receives its blood supply from whatever structures underlying it, which can be branched from the aorta (intercostal, superior phrenic and inferior phrenic arteries), the internal thoracic (pericardiacophrenic, anterior intercostal and musculophrenic branches), or their anastomosis.

The visceral pleurae are innervated by splanchnic nerves from the pulmonary plexus, which also innervates the lungs and bronchi. The parietal pleurae however, like their blood supplies, receive nerve supplies from different sources. The costal pleurae (including the portion that bulges above the thoracic inlet) and the periphery of the diaphragmatic pleurae are innervated by the intercostal nerves from the enclosing rib cage, which branches off from the T1-T12 thoracic spinal cord. The mediastinal pleurae and central portions of the diaphragmatic pleurae are innervated by the phrenic nerves. which branches off the C3-C5 cervical cord. Only the parietal pleurae contain somatosensory nerves and are capable of perceiving pain.

Development

edit

During the third week of embryogenesis, each lateral mesoderm splits into two layers. The dorsal layer joins the overlying somites and ectoderm to form the somatopleure; and the ventral layer joins the underlying endoderm to form the splanchnopleure.[2] The dehiscence of these two layers creates a fluid-filled cavity on each side, and with the ventral infolding and the subsequent midline fusion of the trilaminar disc, forms a pair of intraembryonic coeloms anterolaterally around the gut tube during the fourth week, with the splanchnopleure on the inner cavity wall and the somatopleure on the outer cavity wall.

The cranial end of the intraembryonic coeloms fuse early to form a single cavity, which rotates invertedly and apparently descends in front of the thorax, and is later encroached by the growing primordial heart as the pericardial cavity. The caudal portions of the coeloms fuse later below the umbilical vein to become the larger peritoneal cavity, separated from the pericardial cavity by the transverse septum. The two cavities communicate via a slim pair of remnant coeloms adjacent to the upper foregut called the pericardioperitoneal canal. During the fifth week, the developing lung buds begin to invaginate into these canals, creating a pair of enlarging cavities that encroach into the surrounding somites and further displace the transverse septum caudally — namely the pleural cavities. The mesothelia pushed out by the developing lungs arise from the splanchnopleure, and become the visceral pleurae; while the other mesothelial surfaces of the pleural cavities arise from the somatopleure, and become the parietal pleurae.

The tissue separating the newly formed pleural cavities from the pericardial cavity are known as the pericardiopleural membranes, which later become the side walls of the fibrous pericardium. The transverse septum and the displaced somites fuse to form the pleuroperitoneal membranes, which separates the pleural cavities from the peritoneal cavity and later becomes the diaphragm.

Function

edit

The pleural cavity, with its associated pleurae, aids optimal functioning of the lungs during breathing. The pleural cavity also contains pleural fluid, which acts as a lubricant and allows the pleurae to slide effortlessly against each other during respiratory movements.[3] Surface tension of the pleural fluid also leads to close apposition of the lung surfaces with the chest wall. This relationship allows for greater inflation of the alveoli during breathing. The pleural cavity transmits movements of the ribs muscles to the lungs, particularly during heavy breathing. During inhalation the external intercostals contract, as does the diaphragm. This causes the expansion of the chest wall, that increases the volume of the lungs. A negative pressure is thus created and inhalation occurs.

Pleural fluid

edit

Pleural fluid is a serous fluid produced by the serous membrane covering normal pleurae. Most fluid is produced by the exudation in parietal circulation (intercostal arteries) via bulk flow and reabsorbed by the lymphatic system.[4] Thus, pleural fluid is produced and reabsorbed continuously. The composition and volume is regulated by mesothelial cells in the pleura.[5] In a normal 70 kg human, a few milliliters of pleural fluid is always present within the intrapleural space.[6] Larger quantities of fluid can accumulate in the pleural space only when the rate of production exceeds the rate of reabsorption. Normally, the rate of reabsorption increases as a physiological response to accumulating fluid, with the reabsorption rate increasing up to 40 times the normal rate before significant amounts of fluid accumulate within the pleural space. Thus, a profound increase in the production of pleural fluid—or some blocking of the reabsorbing lymphatic system—is required for fluid to accumulate in the pleural space.

Pleural fluid circulation

edit

The hydrostatic equilibrium model, viscous flow model and capillary equilibrium model are the three hypothesised models of circulation of pleural fluid.[7]

According to the viscous flow model, the intra pleural pressure gradient drives a downward viscous flow of pleural fluid along the flat surfaces of ribs. The capillary equilibrium model states that the high negative apical pleural pressure leads to a basal-to-apical gradient at the mediastinal pleural surface, leading to a fluid flow directed up towards the apex (helped by the beating heart and ventilation in lungs).Thus the recirculation of fluid occurs. Finally there is a traverse flow from margins to flat portion of ribs completes the fluid circulation.[8][9]

Absorption occurs into lymphatic vessels at the level of the diaphragmatic pleura.[10]

Clinical significance

edit

Pleural effusion

edit
 
A pleural effusion can form when fluid builds up in the pleural cavity (labelled as pleural space).
Main article: Pleural effusion

A pathologic collection of pleural fluid is called a pleural effusion. Mechanisms:

  1. Lymphatic obstruction
  2. Increased capillary permeability
  3. Decreased plasma colloid osmotic pressure
  4. Increased capillary venous pressure
  5. Increased negative intrapleural pressure

Pleural effusions are classified as exudative (high protein) or transudative (low protein). Exudative pleural effusions are generally caused by infections such as pneumonia (parapneumonic pleural effusion), malignancy, granulomatous disease such as tuberculosis or coccidioidomycosis, collagen vascular diseases, and other inflammatory states. Transudative pleural effusions occur in congestive heart failure (CHF), cirrhosis or nephrotic syndrome.

Localized pleural fluid effusion noted during pulmonary embolism (PE) results probably from increased capillary permeability due to cytokine or inflammatory mediator release from the platelet-rich thrombi.[11]

Transudate[12] Exudative causes[12]
* Congestive heart failure (CHF) * Malignancy

Pleural fluid analysis

edit

When accumulation of pleural fluid is noted, cytopathologic evaluation of the fluid, as well as clinical microscopy, microbiology, chemical studies, tumor markers, pH determination and other more esoteric tests are required as diagnostic tools for determining the causes of this abnormal accumulation. Even the gross appearance, color, clarity and odor can be useful tools in diagnosis. The presence of heart failure, infection or malignancy within the pleural cavity are the most common causes that can be identified using this approach.[13]

Gross appearance

edit
  • Clear straw-colored: If transudative, no further analysis needed. If exudative, additional studies needed to determine cause (cytology, culture, biopsy).
  • Cloudy, purulent, turbid: Infection, empyema, pancreatitis, malignancy.
  • Pink to red/bloody: Traumatic tap, malignancy, pulmonary infarction, intestinal infarction, pancreatitis, trauma.
  • Green-white, turbid: Rheumatoid arthritis with pleural effusion.
  • Green-brown: Biliary disease, bowel perforation with ascites.
  • Milky-white or yellow and bloody: Chylous effusion.
  • Milky or green, metallic sheen: Pseudochylous effusion.
  • Viscous (hemorrhagic or clear): Mesothelioma.
  • Anchovy-paste (or 'chocolate sauce'): Ruptured amoebic liver abscess.[12]

Microscopic appearance

edit

Microscopy may show resident cells (mesothelial cells, inflammatory cells) of either benign or malignant etiology. Evaluation by a cytopathologist is then performed and a morphologic diagnosis can be made. Neutrophils are numerous in pleural empyema. If lymphocytes predominate and mesothelial cells are rare, this is suggestive of tuberculosis. Mesothelial cells may also be decreased in cases of rheumatoid pleuritis or post-pleurodesis pleuritis. Eosinophils are often seen if a patient has recently undergone prior pleural fluid tap. Their significance is limited.[14]

If malignant cells are present, a pathologist may perform additional studies including immunohistochemistry to determine the etiology of the malignancy.

Chemical analysis

edit

Chemistry studies may be performed including pH, pleural fluid:serum protein ratio, LDH ratio, specific gravity, cholesterol and bilirubin levels. These studies may help clarify the etiology of a pleural effusion (exudative vs transudative). Amylase may be elevated in pleural effusions related to gastric/esophageal perforations, pancreatitis or malignancy. Pleural effusions are classified as exudative (high protein) or transudative (low protein).

In spite of all the diagnostic tests available today, many pleural effusions remain idiopathic in origin. If severe symptoms persist, more invasive techniques may be required. In spite of the lack of knowledge of the cause of the effusion, treatment may be required to relieve the most common symptom, dyspnea, as this can be quite disabling. Thoracoscopy has become the mainstay of invasive procedures as closed pleural biopsy has fallen into disuse.

Disease

edit
Main article: Pleural disease

Diseases of the pleural cavity include:

See also

edit
  • Coin test, medical diagnostic test for a punctured lung

References

edit
  1. ^ a b Saladin, Kenneth S. (2011). Human anatomy (3rd ed.). New York: McGraw-Hill. pp. 643–644. ISBN 9780071222075. OCLC 780984149.
  2. ^ Larsen, William J. (2001). Human embryology (3. ed.). Philadelphia, Pa.: Churchill Livingstone. p. 138. ISBN 9780443065835. OCLC 902010725.
  3. ^ Light 2007, p. 1.
  4. ^ Miserocchi, G. (2009-12-01). "Mechanisms controlling the volume of pleural fluid and extravascular lung water". European Respiratory Review. 18 (114): 244–252. doi:10.1183/09059180.00002709. ISSN 0905-9180. PMID 20956149.
  5. ^ Zocchi, L. (December 2002). "Physiology and pathophysiology of pleural fluid turnover". European Respiratory Journal. 20 (6): 1545–1558. doi:10.1183/09031936.02.00062102. hdl:2434/9438. ISSN 0903-1936. PMID 12503717.
  6. ^ Widmaier, Eric P.; Raff, Hershel; Strang, Kevin T. (2006). Vander's human physiology : the mechanisms of body function (10th ed.). Boston, Massachusetts: McGraw-Hill. ISBN 978-0072827415.
  7. ^ Casha, Aaron R.; Caruana-Gauci, Roberto; Manche, Alexander; Gauci, Marilyn; Chetcuti, Stanley; Bertolaccini, Luca; Scarci, Marco (April 2017). "Pleural pressure theory revisited: a role for capillary equilibrium". Journal of Thoracic Disease. 9 (4): 979–989. doi:10.21037/jtd.2017.03.112. ISSN 2072-1439. PMC 5418293. PMID 28523153.
  8. ^ Boron, Walter F.; Boulpaep, Emile L. (2015). Fisiologia medica (2). Elsevier Mosby. ISBN 978-85-352-6851-5. OCLC 949753083.
  9. ^ Lai-Fook, Stephen J. (April 2004). "Pleural mechanics and fluid exchange". Physiological Reviews. 84 (2): 385–410. doi:10.1152/physrev.00026.2003. ISSN 0031-9333. PMID 15044678.
  10. ^ Shintani, Yasushi; Funaki, Soichiro; Ose, Naoko; Kawamura, Tomohiro; Kanzaki, Ryu; Minami, Masato; Okumura, Meinoshin (June 2018). "Air leak pattern shown by digital chest drainage system predict prolonged air leakage after pulmonary resection for patients with lung cancer". Journal of Thoracic Disease. 10 (6): 3714–3721. doi:10.21037/jtd.2018.05.150. ISSN 2072-1439. PMC 6051872. PMID 30069369.
  11. ^ Porcel, J.M.; R.W. Light (July 2008). "Pleural effusions due to pulmonary embolism". Current Opinion in Pulmonary Medicine. 14 (4): 337–42. doi:10.1097/MCP.0b013e3282fcea3c. PMID 18520269. S2CID 44337698.
  12. ^ a b c Galagan, Katherine A. (2006). Color Atlas of Body Fluids: an illustrated field guide based on proficiency testing. Northfield, Ill.: CAP Press. ISBN 9780930304911. OCLC 78070199.
  13. ^ Shidham, Vinod B.; Atkinson, Barbara F. (2007). Cytopathologic diagnosis of serous fluids (1st ed.). Philadelphia, Pennsylvania: Saunders Elsevier. ISBN 978-1416001454. OCLC 1239350014.
  14. ^ De Mais, Daniel. ASCP Quick Compendium of Clinical Pathology, 2nd. Ed. ASCP Press, Chicago, 2009.

Sources

edit
edit
Retrieved from "https://en.wikipedia.org/w/index.php?title=Pleural_cavity&oldid=1253963602"